DRC Ebola vaccine research gets $3.9 million as deaths surpass 3,500

Research into an Ebola vaccine in the Democratic Republic of Congo has received $3.9 million in funding, as the number of deaths linked to the outbreak has exceeded 3,500. The development highlights continued international efforts to address the disease amid a severe public health crisis in the country.